伊立替康联合氟尿嘧啶/亚叶酸钙治疗晚期大肠癌疗效分析

    Efficasy of irinotecan plus fuorouracil/leucovorin in treatment of patients with advanced colorectal cancer

    • 摘要: 目的:评价伊立替康联合氟尿嘧啶/亚叶酸钙方案治疗晚期大肠癌的疗效及不良反应。方法:第1天,应用伊立替康150~180mg/m2静脉滴注,90min;氟尿嘧啶500mg静脉推注;亚叶酸钙500mg静脉滴注,2h;氟尿嘧啶1250~1500mg/m2输液泵持续静脉滴注44h,每2周期重复,至少完成2周期。结果:全组共化疗73周期,20例化疗者,19例可评价疗效,完全缓解1例,部分缓解6例,疾病稳定5例,进展7例。主要不良反应为白细胞减少、迟发性腹泻、恶心、呕吐,无化疗相关性死亡。结论:伊立替康联合氟尿嘧啶/亚叶酸钙方案治疗晚期大肠癌疗效好,毒副反应可以预防、控制,可以广泛应用于临床。

       

      Abstract: Objective:To observe the effects and side effects of irinotecan plus fuorouracil/leucovorin in treatment of patients with advanced colorectal cancer.Methods:Irinotecan 150-180 mg/m2 intravenous drip (90 min),fuorouracil 500 mg bolus and leucovorin 500 mg intravenous drip (2 h) were administered on day 1;1 250-1 500 mg/m2 was injected intravenously for 44 h,at least 2 cycles.Results:All the 20 patients received 73 cycles of the chemotherapy,and 19 patients were assessable.Complete remission was observed in 1 case,partial remission in 6 cases,disease stable in 5 cases and disease progress in 7 cases.The main adverse reactions were leucopenia,diarrhea,nausea and vomiting.No chemotherapy related death was noted.Conclusions:The combination therapy of irinotecan plus fuorouracil/leucovorin is effective for treatment of patients with advanced colorectal cancer,and the adverse reaction can be obviated or controlled.This therapy can be widely used in clinical application.

       

    /

    返回文章
    返回